WHO ICTRP trial
Efficacy and safety of Mesenchymal stem cell injection for the treatment of…
ChiCTR-TRC-08000080 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-TRC-08000080 |
|---|---|
| Public title | Efficacy and safety of Mesenchymal stem cell injection for the treatment of acute myocardial infarction: a single blinding, muticenter randomized control trial. |
| Scientific title | Efficacy and safety of Mesenchymal stem cell injection for the treatment of acute myocardial infarction: a single blinding, muticenter randomized control trial. |
| Primary sponsor | Navy general hospital of China liberation army |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Pilot study |
| Countries | China |
| Conditions | ST-elevated acute myocardial infarction (ST-AMI) |
| Interventions | Group A:Routine therapy as Guideline recommended+ PCI;Group B:Routine therapy as Guideline recommended+ PCI+transplantation of (MSCs) |
| Registration date | Apr 10, 2008 |
| Target size | Group A:120;Group B:120 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: